Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
NCT03745378
·
clinicaltrials.gov ↗
COMPLETED
Status
1881
Enrollment
OTHER
Sponsor class
Conditions
Polycythemia Vera
Essential Thrombocythemia
Myelofibrosis
Interventions
OTHER:
JAK2V617F mutation
Sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS